About
The Institute of Vocational Training AKMI is the largest VET provider in Greece and one of the 7 largests in Europe. It was founded back in 1989 and today is active in 7 cities across Greece (Athens, Piraeus, Thessaloniki, Crete, Larissa, Rhodes, Chalkida) representing almost 60% of the total VET sector in the country providing post-secondary education, of EQF levels 3-5. Every year, approximately 14.600 active students are enrolled with the aim to study one of the 107 specialties, in more than 340 laboratories in 14 different sectors within more than 37.500 m2 of infrastructure across the country. The fields of study in the campuses of Athens are numerous and in all of them, AKMI gives the students tools to collaborate and problem solve, brainstorm and reflect. Apart from the technical part of learning, the experienced educators ensure an inclusive community among the students and cultivate a safe environment, allowing them to open up, discover new directions and ultimately, helping them create a new mindset. Social Inclusion and Gender Gap are important issues for AKMI, which youth can reform and gradually resolve through education. In one word, AKMI hopes that with proper education, the youth can become productive, scientificoriented, broad-minded, and ideal citizens of the society as the society is significantly influenced by this category of people.
Areas of Activity
IHI Topic 1: IHI European healthcare incubator networkIHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studiesIHI Topic 3: Decode the immuno-science of age-related mediated diseasesHORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatmentHORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancersHORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypesHORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes researchHORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicinesHORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies